Previous 10 | Next 10 |
Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infec...
LM Funding America (NASDAQ:LMFA) +45%. Sonoma Pharmaceuticals SNOA +31% with extended approval for Nanocyn in Australia ABVC BioPharma (NASDAQ:ABVC) +23%. Companhia Brasileira de Distribuicao (NYSE:CBD) +14%. Avadel Pharmaceuticals (NASDAQ:AVDL) +13%. Checkmate Pharmaceuticals CMPI&...
Gainers: Aditxt (NASDAQ:ADTX) +22%, Synaptogenix (NASDAQ:SNPX) +17%, Shineco (NASDAQ:TYHT) +13%, SmileDirectClub (NASDAQ:SDC) +12%, Silverback Therapeutics (NASDAQ:SBTX) +9%. Losers: UpHealth (NYSE:UPH) -34%, Unity Biotechnology (NASDAQ:UBX)...
Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infec...
Gainers: Xenon Pharmaceuticals XENE +84%. Elmira Savings Bank ESBK +67%. Superior Drilling Products (NYSE:SDPI) +38%. Mexco Energy (NYSE:MXC) +36%. American Resources AREC +33%. Ring Energy (NYSE:REI) +22%. Nine Energy Service (NYSE:NINE) +20%. Progenity (NASDAQ:PROG) +18%. Lio...
Gainers: Xenon Pharmaceuticals XENE +76%, Milestone Scientific (NYSE:MLSS) +15%, Clene (NASDAQ:CLNN) +12%, OpGen OPGN +11%, Adverum Biotechnologies ADVM +8%. Losers: Owlet (NYSE:OWLT) -25, REGENXBIO (NASDAQ:RGNX) -21%, Omeros (NASDAQ...
Gainers: Progenity (NASDAQ:PROG) +29%, Biomerica (NASDAQ:BMRA) +28%, Atea Pharmaceuticals (NASDAQ:AVIR) +19%, Silverback Therapeutics (NASDAQ:SBTX) +13%, Codexis (NASDAQ:CDXS) +12%. Losers: Omeros (NASDAQ:OMER) -41%, Adagio Therapeut...
The following slide deck was published by Silverback Therapeutics, Inc. in conjunction with this event. For further details see: Silverback Therapeutics (SBTX) presents at ESMO Congress 2021
Healthcare stocks in the S&P 500 edged past the ~0.6% loss in the broader index over the week to end ~0.2% lower, becoming the fourth best performing sector. Among stocks with more than $300M market cap and over 100K average daily volume over the past five sessions, BELLUS Health (NA...
Commodity prices have played a significant role on Wall Street this week -- a trend that continued Thursday as a drop in gold sparked a slide in mining stocks. Newmont (NYSE:NEM), Barrick Gold (NYSE:GOLD), Kinross Gold (NYSE:KGC) and Agnico Eagle Mines (NYSE:AEM) all staged notable retreats. ...
News, Short Squeeze, Breakout and More Instantly...
Silverback Therapeutics Inc. Company Name:
SBTX Stock Symbol:
NASDAQ Market:
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in Europe Positive CHMP opinion and recommendation for approval of a mixed application for marketing authorization based on comprehensi...
neffy ® (epinephrine nasal spray) New Drug Application (NDA) and CRL response under review by FDA with anticipated review completion by early October 2024 Response submitted for neffy Marketing Authorization Application (MAA) to EMA’s CHMP; CHMP...
CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by CHMP, and includes results from a repeat dose PK/PD study of neffy under NAC conditions and updated ...